12-102855151-A-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000277.3(PAH):c.691T>C(p.Ser231Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S231F) has been classified as Pathogenic.
Frequency
Consequence
NM_000277.3 missense
Scores
Clinical Significance
Conservation
Publications
- phenylketonuriaInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Myriad Women’s Health
- classic phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- maternal phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild hyperphenylalaninemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- mild phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuriaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PAH | NM_000277.3 | c.691T>C | p.Ser231Pro | missense_variant | Exon 6 of 13 | ENST00000553106.6 | NP_000268.1 | |
| PAH | NM_001354304.2 | c.691T>C | p.Ser231Pro | missense_variant | Exon 7 of 14 | NP_001341233.1 | ||
| PAH | XM_017019370.2 | c.691T>C | p.Ser231Pro | missense_variant | Exon 6 of 7 | XP_016874859.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PAH | ENST00000553106.6 | c.691T>C | p.Ser231Pro | missense_variant | Exon 6 of 13 | 1 | NM_000277.3 | ENSP00000448059.1 | ||
| PAH | ENST00000549111.5 | n.787T>C | non_coding_transcript_exon_variant | Exon 6 of 6 | 1 | |||||
| PAH | ENST00000307000.7 | c.676T>C | p.Ser226Pro | missense_variant | Exon 7 of 14 | 5 | ENSP00000303500.2 | |||
| PAH | ENST00000551988.5 | n.*128T>C | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Phenylketonuria Pathogenic:6
This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 231 of the PAH protein (p.Ser231Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with phenylketonuria (PMID: 18346471, 27682710). ClinVar contains an entry for this variant (Variation ID: 102786). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PAH protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PAH function (PMID: 8535444, 10394930). For these reasons, this variant has been classified as Pathogenic. -
- -
Variant summary: PAH c.691T>C (p.Ser231Pro) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251314 control chromosomes. c.691T>C has been reported in the literature in multiple individuals affected with Phenylalanine Hydroxylase Deficiency (Phenylketonuria, e.g. Shirzadeh_2018). These data indicate that the variant is very likely to be associated with disease. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
The p.Ser231Pro variant has been reported at least seven individuals with phenylketonuria (PKU) in the homozygous or compound heterozygous state (Effat 1999, Daniele 2008, Hamzelhoei 2012, Ajami 2013), and was not identified in large population studies. In vitro functional assays suggest complete loss of enzymatic activity (Dianzani 1995). In summary, this variant meets our criteria to be classified as pathogenic for PKU in an autosomal recessive manner for PKU based upon presence in affected individuals, absence from controls, and functional evidence (http://personalizedmedicine.partners.org/Laboratory-For-Molecular-Medicine/). -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at